Sterimed
FranceWho owns Sterimed?
Sterimed is a French MedTech company, currently owned by Societe Generale Capital Partenaires since 2025 and 2 other investors. It changed hands in 2025, when Meanings Capital Partners and Sagard sold.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Key facts
- ·Co-held by Societe Generale Capital Partenaires, GENEO Capital Entrepreneur and IK Partners since 2025.
- ·Average hold across 2 realized cycles: 7 years.
- ·5 distinct PE sponsors across ownership cycles.
Ownership history
5 ownership periods · co-invest detected · 1 lender on file
Meanings Capital Partners sold Sterimed to IK Partners in 2025 after 7 years.
Sagard sold Sterimed to IK Partners in 2025 after 6 years.
More from IK X (Mid Cap)
Other portfolio companies in the same fund.
Sweden
UK
NorwayMore PE-backed in MedTech
Comparable medtech deals from other GPs.
US
GermanyQuestions
Who owns Sterimed?
Sterimed is currently owned by Societe Generale Capital Partenaires, GENEO Capital Entrepreneur and 1 other, through IK X (Mid Cap), since 2025.
When did Societe Generale Capital Partenaires and 2 others acquire Sterimed?
Societe Generale Capital Partenaires and 2 others acquired Sterimed in 2025.
Who did Sterimed sell to?
Meanings Capital Partners and Sagard sold Sterimed to IK Partners in 2025 (Secondary).
Who has owned Sterimed over time?
Sterimed has been through 6 private-equity ownership periods: Meanings Capital Partners · via Meanings Private Equity Growth (MPEG) · 2018–2025 · sold to IK Partners · (Secondary); Sagard · via Sagard · 2019–2025 · sold to IK Partners · (Secondary); Capza · via CAPZA 6 Private Debt · 2021–2025; Societe Generale Capital Partenaires · via SGCP Evergreen (balance sheet) · since 2025; GENEO Capital Entrepreneur · via GENEO Capital · 2025–2025; IK Partners · via IK X (Mid Cap) · 2025–2025.